Search CommunityWalk:


Cortica Neurosciences Inc

155 Gibbs Street #436
Rockville, MD, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Cortica Neurosciences Inc is a biopharmaceutical company focused on the development and commercialization of disease-altering therapies to prevent cellular degeneration of the brain. It was established in 2006 by J. Kelly Ganjei & Luciano D'Adamio.

Cortica Neurosciences' technology is dependent on a pivotal role of BR12 in the processing of Amyloid precursor protein. It has novel proprietary models of AD that have been used in the development of peptide drugs.

Cortica Neurosciences has developed suite of therapeutic product candidates for neurodegenerative disease. The company's product pipeline includes: RGX-100 (Intranasal peptide) for the treatment of Alzheimer's disease; RGX-200 (R&D Stage Small molecule) for the treatment of Alzheimer's disease and dementia; and RGX-Tgx: Transgenic animal models of Alzheimer's disease and cognitive decline.